A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for …

RK Hoyles, RW Ellis, J Wellsbury… - … : Official Journal of …, 2006 - Wiley Online Library
Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic
sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was …

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for …

RK Hoyles, RW Ellis, J Wellsbury… - Arthritis & …, 2006 - researchportal.bath.ac.uk
Objective: The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic
sclerosis (SSc) has hampered an evidence-based approach to treatment. This RCT was …

[引用][C] A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral …

RK HOYLES, RW ELLIS, NM FOLEY… - Arthritis and …, 2006 - pascal-francis.inist.fr
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of
corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the …

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for …

RK Hoyles, RW Ellis, J Wellsbury… - Arthritis Care & …, 2006 - research.manchester.ac.uk
Objective. The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic
sclerosis (SSc) has hampered an evidence-based approach to treatment. This RCT was …

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for …

R Hoyles, R Ellis, J Wellsbury, B Lees… - 0004 …, 2006 - escholar.manchester.ac.uk
OBJECTIVE: The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in
systemic sclerosis (SSc) has hampered an evidence-based approach to treatment. This RCT …

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for …

RK Hoyles, RW Ellis, J Wellsbury, B Lees… - Arthritis and …, 2006 - europepmc.org
Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic
sclerosis (SSc) has hampered an evidence-based approach to treatment. This RCT was …

[引用][C] A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral …

H RK - Arthritis Rheum, 2006 - cir.nii.ac.jp
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids
and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary …

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for …

RK Hoyles, RW Ellis, J Wellsbury, B Lees, P Newlands… - 2006 - pubmed.ncbi.nlm.nih.gov
Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic
sclerosis (SSc) has hampered an evidence-based approach to treatment. This RCT was …

A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for …

RK Hoyles, RW Ellis, J Wellsbury… - … : Official Journal of …, 2006 - Wiley Online Library
Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic
sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was …

[PDF][PDF] A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Corticosteroids and Intravenous Cyclophosphamide Followed by Oral …

RK Hoyles, RW Ellis, J Wellsbury, B Lees… - ARTHRITIS & …, 2006 - academia.edu
Objective. The lack of randomized controlled tri-als (RCTs) in pulmonary fibrosis in systemic
sclerosis (SSc) has hampered an evidence-based approach to treatment. This RCT was …